Search Results - "Schijf, C P T"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Early identification of persistent trophoblastic disease with serum hCG concentration ratios by van Trommel, N E, Ngo Duc, H, Massuger, L F A G, Schijf, C P T, Sweep, C G J, Thomas, C M G

    “…The objective of the present study was to assess the diagnostic potential of serum human chorionic gonadotropin (hCG) ratios obtained at different intervals…”
    Get more information
    Journal Article
  2. 2

    The value of loop electrosurgical conization in the treatment of stage IA1 microinvasive carcinoma of the uterine cervix by Bekkers, R L M, Keyser, K G G, Bulten, J, Hanselaar, A G J M, Schijf, C P T, Boonstra, H, Massuger, L F A G

    “…The objective of this study is to assess the value of Loop Electrosurgical Conization (LEC) in the treatment of stage IA1 microinvasive squamous cell carcinoma…”
    Get more information
    Journal Article
  3. 3

    Dosimetric analysis of chimeric monoclonal antibody cMOv18 IgG in ovarian carcinoma patients after intraperitoneal and intravenous administration by Buijs, W C, Tibben, J G, Boerman, O C, Molthoff, C F, Massuger, L F, Koenders, E B, Schijf, C P, Siegel, J A, Corstens, F H

    Published in European journal of nuclear medicine (01-11-1998)
    “…In this study the potential of intraperitoneal (i.p.) and intravenous (i.v.) administration of chimeric iodine-131-labelled MOv18 IgG for radioimmunotherapy…”
    Get full text
    Journal Article
  4. 4

    Humoral anti-OV-TL 3 response after the intravenous administration of radiolabelled Fab' or F(ab')2 fragments in ovarian cancer patients by Tibben, J G, Thomas, C M, Massuger, L F, Segers, M F, Schijf, C P, Corstens, F H, Boerman, O C

    Published in Nuclear medicine communications (01-10-1995)
    “…The human anti-mouse antibody (HAMA) response was determined in the serum of patients suspected of having ovarian cancer who underwent radioimmunoscintigraphy…”
    Get more information
    Journal Article
  5. 5

    Leiomyomatosis Peritonealis Disseminata: Does Malignant Transformation Occur? A Literature Review by Bekkers, R.L.M., Willemsen, W.N.P., Schijf, C.P.T., Massuger, L.F.A.G., Bulten, J., Merkus, J.M.W.M.

    Published in Gynecologic oncology (01-10-1999)
    “…Leiomyomatosis peritonealis disseminata (LPD) is a rare smooth muscle tumor. In the literature more than 100 cases have been described. LPD is characterized by…”
    Get full text
    Journal Article
  6. 6

    Incidence and Effect on Survival of Abdominal Wall Metastases at Trocar or Puncture Sites Following Laparoscopy or Paracentesis in Women with Ovarian Cancer by Kruitwagen, R.F.P.M., Swinkels, B.M., Keyser, K.G.G., Doesburg, W.H., Schijf, Ch.P.Th

    Published in Gynecologic oncology (01-02-1996)
    “…The aim of this retrospective study was to examine the incidence and prognostic significance of abdominal wall metastases in patients with ovarian cancer…”
    Get full text
    Journal Article
  7. 7

    Coexisting high-grade glandular and squamous cervical lesions and human papillomavirus infections by Bekkers, R L M, Bulten, J, Wiersma-van Tilburg, A, Mravunac, M, Schijf, C P T, Massuger, L F A G, Quint, W G V, Melchers, W J G

    Published in British journal of cancer (01-09-2003)
    “…The frequency of high-risk human papillomavirus (hr-HPV) genotypes in patients with adenocarcinoma in situ (ACIS) with coexisting cervical intraepithelial…”
    Get full text
    Journal Article
  8. 8

    Ovarian tumour in a girl with chronic abdominal pain and distension by Loeffen, J L C M, Wijnen, M, Schijf, C P T, van Wieringen, P

    Published in Nederlands tijdschrift voor geneeskunde (25-03-2006)
    “…A 12-year-old girl presented with chronic abdominal pain and distension that had persisted for 6 and 3 months, respectively. The cause was a Sertoli-Leydig…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Diathermy loop excision in the management of cervical intraepithelial neoplasia: diagnosis and treatment in one procedure by Keijser, K G, Kenemans, P, van der Zanden, P H, Schijf, C P, Vooijs, G P, Rolland, R

    “…Diathermy loop excision was performed as a new diagnostic-treatment in patients with cervical cytologic diagnoses consistent with an epithelial abnormality. A…”
    Get more information
    Journal Article
  11. 11

    Improvement of Clinical Staging in Cervical Cancer with Serum Squamous Cell Carcinoma Antigen and CA 125 Determinations by Massuger, Leon F.A.G., Koper, Norbert P., Thomas, Chris M.G., Dom, Koen E.L., Schijf, Charles P.T.

    Published in Gynecologic oncology (01-03-1997)
    “…Staging of cervical cancer is routinely performed by means of examination under anesthesia in combination with radiographic and/or endoscopic techniques. This…”
    Get full text
    Journal Article
  12. 12

    Ovarian cancer incidence (1989–1991) and mortality (1954–1993) in the Netherlands by Koper, Norbert P., Kiemeney, Lambertus A.L.M., Massuger, Leon F.A.G., Thomas, Chris M.G., Schijf, Charles P.T., Verbeek, André L.M.

    Published in Obstetrics and gynecology (New York. 1953) (01-09-1996)
    “…To examine ovarian cancer incidence and mortality in the Netherlands, and to relate trends in mortality to changes in parity and use of oral contraceptives…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Differences in serum lipids, lipoproteins, sex hormone binding globulin and testosterone between the follicular and the luteal phase of the menstrual cycle by Schijf, C P, van der Mooren, M J, Doesburg, W H, Thomas, C M, Rolland, R

    Published in Acta endocrinologica (Copenhagen) (01-08-1993)
    “…Fifty-four healthy women were studied during the follicular and the luteal phase of one menstrual cycle to determine possible cyclic influences on several…”
    Get more information
    Journal Article
  15. 15

    Analytical and clinical performance of improved Abbott IMx CA 125 assay: comparison with Abbott CA 125 RIA by Thomas, C M, Massuger, L F, Segers, M F, Schijf, C P, Doesburg, W H, Wobbes, T

    Published in Clinical chemistry (Baltimore, Md.) (01-02-1995)
    “…We compared the improved Abbott IMx cancer antigen (CA) 125 assay (cat. no. 7A89) with the Abbott CA 125 RIA. Serum specimens were from healthy perimenopausal…”
    Get more information
    Journal Article
  16. 16
  17. 17
  18. 18

    Tumour detection and localization using 99Tcm-labelled OV-TL 3 Fab' in patients suspected of ovarian cancer by Tibben, J G, Massuger, L F, Claessens, R A, Schijf, C P, Pak, K Y, Strijk, S P, Kenemans, P, Corstens, F H

    Published in Nuclear medicine communications (01-12-1992)
    “…Fab' fragments of the monoclonal antibody OV-TL 3, that recognizes an ovarian carcinoma-associated antigen (OA3), were labelled with 99Tcm using D-glucarate as…”
    Get more information
    Journal Article
  19. 19

    Kinetics and biodistribution in relation to tumour detection with 111In-labelled OV-TL 3 F(ab')2 in patients with ovarian cancer by Massuger, L F, Claessens, R A, Kenemans, P, Verheijen, R H, Boerman, O C, Meeuwis, A P, Schijf, C P, Buijs, W C, Hanselaar, T G, Corstens, F H

    Published in Nuclear medicine communications (01-07-1991)
    “…The biological behaviour of 111In-labelled OV-TL 3 F(ab')2 was studied in 22 patients with suspected ovarian cancer. After i.v. injection with 140 MBq…”
    Get more information
    Journal Article
  20. 20